Blood Tests Advance Alzheimer's Detection in Down Syndrome
- High-risk group: People with Down syndrome face over 90% lifetime Alzheimer's risk, with nearly all showing amyloid plaques by age 40.
- Promising...

Created by Er Yao
Evidence‑based updates on blood markers, diseases, lifestyle, donation and forensic analysis
Explore the latest content tracked by Blood Health Insights
Low blood pressure (below 90/60 mm Hg) can trigger dizziness or lightheadedness after workouts due to post-exercise hypotension and rapid position...
If you have sickle cell trait, standard immunoassay HbA1c tests may underestimate your levels and miss prediabetes or diabetes. Research at ADLM 2026...
A straightforward rule flags high-risk smoldering multiple myeloma: a 0.5 g/dL M-protein increase occurring with a 0.5 g/dL hemoglobin drop signals...
For a 68-year-old with symptomatic CLL, unmutated IGHV, bulky disease, and strong preference for minimal clinic visits, BTKi monotherapy emerges as...
Cholesterol risk assessment is expanding past total LDL levels.
Polycythemia vera (PV) is a rare chronic blood cancer where bone marrow overproduces red blood cells, causing thicker blood and impaired...
Should you stop vitamin D when the sun comes out? It depends on your lifestyle and location.
Two overlooked conditions can distort A1C results in opposite directions, leaving patients misclassified.
Blood tests detecting early Alzheimer's markers work effectively in people with Down syndrome, a high-risk group long excluded from such advances. In...
An energy and fatigue panel evaluates multiple systems in one draw to uncover tiredness causes.
Hemoglobin levels rose progressively in lupus autoimmune hemolytic anemia after type I interferon targeting, reaching statistical significance versus...
High platelet counts and low hemoglobin levels link directly to poor prognosis in vascular disorders, potentially modifying outcomes through their impact on clotting and blood health.
Anemia diagnosis begins with ferritin and red cell indices but grows far more intricate in conditions like MDS, while access gaps persist especially...
The American Society of Hematology has issued 2026 guidelines on diagnosing light chain amyloidosis, a rare blood disorder that is often missed in practice.
Three shifts are reshaping how people track and treat cholesterol for heart health.
A convenient blood-based option for colorectal cancer screening is now FDA-approved, potentially reaching millions overdue for testing.
-...
Labcorp's Marker Genetic Health Panel analyzes 163 genes for over 100 hereditary conditions, covering cancer, cardiovascular, and metabolic risks.
-...